查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年微針給藥系統市場預測：按組件、類型、材料、應用、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383477

2030 年微針給藥系統市場預測：按組件、類型、材料、應用、最終用戶和地區進行的全球分析

Microneedle Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Component, Type, Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球微針給藥系統市場規模為 58.9 億美元，預計在預測期內年複合成長率為 9.4%，到 2030 年將達到 110.4 億美元。

用於藥物、疫苗和其他治療劑的規範且有效的經皮給藥的裝置被稱為微針藥物遞送系統市場。微針是一種微創針，其目的是在皮膚最外層創建微通道，允許皮內或經皮給藥藥物和生物活性物質。該針將用於無痛疫苗接種，提高疫苗接種率並使免疫接種對患者更加友善。

根據 ACS 發表的一篇論文，2020 年 5 月，匹茲堡大學醫學中心和匹茲堡大學的研究人員嘗試開發微針陣列（MNA）。它是一個指尖大小的貼片，帶有 400 個微型針頭，可將尖刺蛋白質片段注入免疫反應最強的皮膚中。

加強公共衛生舉措

微針具有改變疫苗接種等公共衛生活動的巨大潛力，因為它們可以進行無痛和微創的藥物輸送。透過提供比傳統注射更舒適和熟悉的選擇，該小工具改善了疫苗接種的機會並減少了焦慮。透過減少與針頭相關的不適，微針可以提高疫苗的可接受性和依從性，最終提高免疫普及。因此，改善健康和疾病控制的目標與微針給藥系統在公共衛生計畫中的部署是一致的，這是這項尖端醫療技術發展的驅動力。

製造昂貴的微針

製造這些專用設備需要複雜的工程技術、精確的品管以及生物相容性材料的使用。這些因素增加了生產成本，限制了市場潛力。然而，這種成本可能會導致使用微針的產品價格更高。這些費用可能使患者和提供者難以獲得治療並限制治療的採用。

改善藥物吸收和生物利用度

微針在皮膚中形成的微通道使藥物輸送更有效。藥物可以透過微針繞過消化器官系統，這可能會縮短作用時間並提高生物利用度。這可能會導致作用持續時間縮短並提高生物利用度。這可以讓更有效的治療以更低的劑量更有效地給藥，減少副作用的可能性，並有可能改善患者的治療結果。此外，提高藥物吸收和生物利用度的能力代表了藥物傳輸領域的重大進步，使微針成為製藥公司、醫療專業人員和尋求增強治療選擇的患者的一個引人注目的主張。

藥物相容性有限

儘管微針是一種有前途且方便用戶使用的藥物給藥方法，但並非所有藥物都適合該技術。微針的組成和設計可以限制可使用的藥物具有某些品質，例如適當的分子大小、溶解度和穩定性。這種限制限制了可以透過微針有效輸送的藥物和生技藥品的類型，並可能阻止一些基本藥物從這種新型輸送系統中受益。然而，為某些藥物製造基於微針的設備可能需要一些時間和費用。

COVID-19 的影響：

政府的封鎖措施以及醫院和診所的關閉導致因生活方式選擇而導致慢性病患者的護理中斷。隨著 COVID-19 感染頻率的增加，該公司和學術機構正致力於開發用於大流行藥物給藥的指尖大小的皮膚貼片。因此，採用微針進行 COVID-19 疫苗接種影響了大流行期間的市場成長。

塗層微針技術領域預計將在預測期內成為最大

預計在預測期內，塗層微針技術領域將佔據最大佔有率。這項最尖端科技允許在微針表面塗覆生物相容性塗層，以適應多種應用。這些塗層可以提高敏感化學物質的穩定性，控制藥物和治療劑的釋放，並提高微針產品的保存期限。此外，患者體驗和療效的改善正在推動微針給藥系統產業的成長。

預計皮膚科在預測期內年複合成長率最高

皮膚科領域預計將呈現良好的成長動能。微針技術透過給藥精確、微創的藥物、皮膚護理產品和美容治療方式，正在徹底改變皮膚病治療。此外，以微針為基礎的皮膚科手術也稱為微針治療，可以治療多種皮膚問題，包括皺紋、痤瘡疤痕、色素沉著和老化症狀。

佔比最大的地區：

在預測期內，由於感染疾病、皮膚病和慢性病的盛行率不斷上升，給藥系統技術進步的成長以及製造業中先進技術和系統的採用不斷增加，北美將佔據最大的市場佔有率微針。預計會佔據。此外，法規程序包括嚴格的評估、臨床測試和遵守品質標準，以確保患者安全和產品功效。北美微針給藥系統的開發和普及將繼續受到支持新的患者友善給藥技術的政府舉措和法規以及公共衛生優先事項的影響。

複合年複合成長率最高的地區：

由於製藥業的擴張和對先進藥物輸送技術的需求不斷成長，預計亞太地區在預測期內將實現盈利成長。這些舉措的核心是改善微針的成分和結構，改善藥物輸送系統，並擴大其在疫苗接種、皮膚病學和慢性病護理等領域的使用範圍。此外，政府機構和學術機構之間的合作也推動了該地區的技術創新。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球微針給藥系統市場：依組成部分

  • 塗層微針技術
  • 中空微針技術
  • 固體微針技術
  • 其他組件

第6章 全球微針給藥系統市場：依類型

  • 溶解微針技術
  • 多孔微針
  • 3D列印微針
  • 水凝膠微針
  • 其他類型

第7章 全球微針給藥系統市場：依材料分類

  • 生物分解性微針材料
  • 陶瓷
  • 金屬
  • 金屬合金
  • 聚合物
  • 矽
  • 其他材料

第8章 全球微針給藥系統市場：依應用分類

  • 癌症治療
  • 皮膚科
  • 荷爾蒙的輸送
  • 胰島素給藥
  • 腫瘤學
  • 疼痛管理
  • 兒童醫學
  • 經皮經皮
  • 疫苗遞送
  • 其他用途

第9章 全球微針給藥系統市場：依最終用戶分類

  • 藥局
  • 醫院
  • 醫療服務提供方
  • 其他最終用戶

第10章 全球微針給藥系統市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章公司簡介

  • 3M
  • 3D-Micromac AG
  • Becton, Dickinson and Company
  • Candela Corporation
  • Clearside Biomedical, Inc.
  • Corium Inc.
  • Dermaroller GmbH
  • Dynatrace
  • Genex Technologies
  • Georgia Institute of Technology
  • Innoture Medical Technology Limited
  • LTS Lohmann Therapie-Systeme AG
  • Micron Biomedical Inc.
  • Micropoint Technologies
  • My Life Technologies
  • NanoSmart Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • PreCelleon Medical Inc.
  • Rani Therapeutics
  • Raphas Co. Ltd
  • TheraJect Inc.
  • Transdermal Technologies, Inc.
  • Valeritas, Inc.
  • Vaxess Technologies
  • Zosano Pharma
  • Zydis
Product Code: SMRC24325

According to Stratistics MRC, the Global Microneedle Drug Delivery Systems Market is accounted for $5.89 billion in 2023 and is expected to reach $11.04 billion by 2030 growing at a CAGR of 9.4% during the forecast period. The devices for the regulated and effective transdermal delivery of medications, vaccines, and other therapeutic agents is known as the microneedle drug delivery systems market. The goal of microneedles, which are minimally invasive needles, is to make microchannels in the skin's outermost layer so that drugs and bioactive substances can be administered intra- or transdermally. They are used to provide painless vaccination, increasing vaccine coverage and making immunization more patient-friendly.

According to an article published by ACS, in May 2020, the researchers at the University of Pittsburgh Medical Center and the University of Pittsburgh tried to develop a microneedle array (MNA), a fingertip-sized patch with 400 microscopic needles that inject spiked protein fragments into the skin, where an immune response is most potent.

Market Dynamics:

Driver:

Enhancement of public health initiatives

With their painless and minimally intrusive drug delivery capabilities, microneedles hold enormous potential for transforming public health initiatives such as immunization campaigns. By providing a more comfortable and approachable option to traditional injections, these gadgets increase accessibility to immunization and reduce anxiety. Microneedles can promote increased vaccine acceptance and compliance by lessening the discomfort associated with needle injections, which will ultimately result in higher immunization coverage rates. Therefore, the goal of improving health outcomes and disease control is aligned with the deployment of microneedle drug delivery systems in public health programs, which is a driving force behind the development of this cutting-edge medical technology.

Restraint:

Expensive production of microneedles

These specialized gadgets need complex engineering, precise quality control, and the use of biocompatible materials in their creation and manufacturing. These elements limit the market potential by raising the cost of production. However, this cost can lead to increased prices for products that use microneedles. These expenses may restrict the adoption of the treatment by making it difficult for patients and healthcare providers to obtain care.

Opportunity:

Increasing drug absorption and bioavailability

Drug delivery is made more effective by the microchannels that are created in the skin by microneedles. Drugs can avoid the gastrointestinal system due to microneedles, which may result in a shorter duration of action and better bioavailability. This may lead to lower doses of more potent treatments that are more effective, lowering the possibility of adverse effects and enhancing patient outcomes. Furthermore, the capacity to augment drug absorption and bioavailability signifies a significant advancement in the domain of drug delivery, rendering microneedles a compelling choice for pharmaceutical corporations, healthcare professionals, and patients in search of enhanced therapeutic alternatives.

Threat:

Limited drug compatibility

Even though microneedles present a promising and user-friendly method of drug administration, not all drugs are appropriate for use with this technology. Microneedles' composition and design may limit the medications that can be used with them to those that have certain qualities, including the right molecular size, solubility, and stability. This constraint limits the types of drugs and biologics that may be delivered with microneedles in an efficient manner, which may prevent some essential drugs from benefiting from this novel delivery system. However, it can take some time and be expensive to build microneedle-based devices for particular medications.

COVID-19 Impact:

The government's lockdown methods and the hospital and clinic closures resulted in a disruption of care for people with chronic illnesses brought on by their lifestyle choices. Because of the increasing frequency of COVID-19 infections, businesses and academic institutions are concentrating more on developing fingertip-sized skin patches for pandemic medication administration. Thus, the adoption of microneedles for COVID-19 immunization affected the market's growth during the pandemic.

The coated microneedle technology segment is expected to be the largest during the forecast period

Coated microneedle technology segment is expected to hold largest share during the forecast period. With this cutting-edge technology, the surface of microneedles with biocompatible coatings can be coated for a variety of uses. These coatings can be made to improve the stability of sensitive chemicals, control the release of medications or therapeutic agents, or improve the shelf life of microneedle products. Additionally, due to the improved patient experience and efficacy, which is fueling the growth of the microneedle drug delivery systems industry.

The dermatology segment is expected to have the highest CAGR during the forecast period

Dermatology segment is estimated to witness lucrative growth. Microneedle technology is transforming dermatological treatments by providing a precise and minimally invasive way to administer drugs, skincare products, and cosmetic therapies. Furthermore, microneedle-based dermatological operations, also known as microneedling, can treat a variety of skin issues, including wrinkles, acne scars, pigmentation, and aging symptoms.

Region with largest share:

Over the course of the forecast period, North America is anticipated to hold the largest share of the market due to an increase in the prevalence of infectious, skin, and chronic diseases; a growth in the technological advancement of drug delivery systems; an increase in the adoption of highly advanced techniques and systems in the fabrication of microneedles. Additionally, to guarantee patient safety and product efficacy, the regulatory procedure involves stringent evaluations, clinical trials, and adherence to quality standards. The development and uptake of microneedle drug delivery systems in North America will continue to be influenced by government initiatives and regulations that support new and patient-friendly drug delivery technologies as well as the prioritization of public health.

Region with highest CAGR:

The Asia Pacific region is anticipated to have profitable growth during the forecast period as a result of the expanding pharmaceutical sector and the growing need for advanced drug delivery techniques. These initiatives center on improving the composition and structure of microneedles, refining drug delivery systems, and broadening the scope of uses in areas such as vaccination, dermatology, and chronic illness care. Moreover, innovation in the region is also being promoted by partnerships among government agencies and academic institutions.

Key players in the market

Some of the key players in Microneedle Drug Delivery Systems market include: 3M, 3D-Micromac AG, Becton, Dickinson and Company, Candela Corporation, Clearside Biomedical, Inc., Corium Inc., Dermaroller GmbH, Dynatrace, Genex Technologies, Georgia Institute of Technology, Innoture Medical Technology Limited, LTS Lohmann Therapie-Systeme AG, Micron Biomedical Inc., Micropoint Technologies, My Life Technologies, NanoSmart Pharmaceuticals, Inc., Nitto Denko Corporation, PreCelleon Medical Inc., Rani Therapeutics, Raphas Co. Ltd, TheraJect Inc., Transdermal Technologies, Inc., Valeritas, Inc., Vaxess Technologies, Zosano Pharma and Zydis.

Key Developments:

In August 2023, Mind Medicine, a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced that it has entered into a license agreement with Catalent, a leader in enabling the development and supply of better treatments for patients worldwide, to access Catalent's proprietary Zydis® orally disintegrating tablet (ODT) technology.

In December 2022, Emergex looks to microneedle patches with Zosano Pharma acquisition. The assets acquired include intellectual property, license agreements, and manufacturing equipment. They also include Zosano's proprietary microneedle array patch (MAP) intradermal drug delivery system, including a reusable applicator, solid coated microneedle array patch technology, product packaging, methods for formulation and microneedle coating, and specialized equipment, designed and built for clinical and commercial manufacture of the technology.

In November 2022, CGBio, a South Korean healthcare provider, launched a skin trouble care patch, CGDew Derma Regen, in its microneedle pipeline. These microneedle patches are made from a range of materials, such as silicon, titanium, stainless steel, and polymers, to improve the diffusivity of medications to the stratum corneum by forming pores on the skin that are smaller than a micron.

In October 2022, Emergex Vaccines Holding Limited acquired the assets of Zosano Pharma Corporation. The assets include intellectual property, license agreements, manufacturing equipment, Zosano's proprietary microneedle array patch (MAP) intradermal drug delivery system, solid-coated microneedle array patch technology, methods for formulation and microneedle coating, and specialized equipment.

Components Covered:

  • Coated Microneedle Technology
  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Other Components

Types Covered:

  • Dissolving Microneedle Technology
  • Porous Microneedles
  • 3D-Printed Microneedles
  • Hydrogel Microneedles
  • Other Types

Materials Covered:

  • Biodegradable Microneedle Materials
  • Ceramics
  • Metal
  • Metal Alloys
  • Polymer
  • Silicon
  • Other Materials

Applications Covered:

  • Cancer Therapy
  • Dermatology
  • Hormone Delivery
  • Insulin Delivery
  • Oncology
  • Pain Management
  • Pediatric Medicine
  • Transdermal Drug Delivery
  • Vaccine Delivery
  • Other Applications

End Users Covered:

  • Pharmacies
  • Hospitals
  • Healthcare Providers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microneedle Drug Delivery Systems Market, By Component

  • 5.1 Introduction
  • 5.2 Coated Microneedle Technology
  • 5.3 Hollow Microneedle Technology
  • 5.4 Solid Microneedle Technology
  • 5.5 Other Components

6 Global Microneedle Drug Delivery Systems Market, By Type

  • 6.1 Introduction
  • 6.2 Dissolving Microneedle Technology
  • 6.3 Porous Microneedles
  • 6.4 3D-Printed Microneedles
  • 6.5 Hydrogel Microneedles
  • 6.6 Other Types

7 Global Microneedle Drug Delivery Systems Market, By Material

  • 7.1 Introduction
  • 7.2 Biodegradable Microneedle Materials
  • 7.3 Ceramics
  • 7.4 Metal
  • 7.5 Metal Alloys
  • 7.6 Polymer
  • 7.7 Silicon
  • 7.8 Other Materials

8 Global Microneedle Drug Delivery Systems Market, By Application

  • 8.1 Introduction
  • 8.2 Cancer Therapy
  • 8.3 Dermatology
  • 8.4 Hormone Delivery
  • 8.5 Insulin Delivery
  • 8.6 Oncology
  • 8.7 Pain Management
  • 8.8 Pediatric Medicine
  • 8.9 Transdermal Drug Delivery
  • 8.10 Vaccine Delivery
  • 8.11 Other Applications

9 Global Microneedle Drug Delivery Systems Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmacies
  • 9.3 Hospitals
  • 9.4 Healthcare Providers
  • 9.5 Other End Users

10 Global Microneedle Drug Delivery Systems Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 3M
  • 12.2 3D-Micromac AG
  • 12.3 Becton, Dickinson and Company
  • 12.4 Candela Corporation
  • 12.5 Clearside Biomedical, Inc.
  • 12.6 Corium Inc.
  • 12.7 Dermaroller GmbH
  • 12.8 Dynatrace
  • 12.9 Genex Technologies
  • 12.10 Georgia Institute of Technology
  • 12.11 Innoture Medical Technology Limited
  • 12.12 LTS Lohmann Therapie-Systeme AG
  • 12.13 Micron Biomedical Inc.
  • 12.14 Micropoint Technologies
  • 12.15 My Life Technologies
  • 12.16 NanoSmart Pharmaceuticals, Inc.
  • 12.17 Nitto Denko Corporation
  • 12.18 PreCelleon Medical Inc.
  • 12.19 Rani Therapeutics
  • 12.20 Raphas Co. Ltd
  • 12.21 TheraJect Inc.
  • 12.22 Transdermal Technologies, Inc.
  • 12.23 Valeritas, Inc.
  • 12.24 Vaxess Technologies
  • 12.25 Zosano Pharma
  • 12.26 Zydis

List of Tables

  • Table 1 Global Microneedle Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microneedle Drug Delivery Systems Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global Microneedle Drug Delivery Systems Market Outlook, By Coated Microneedle Technology (2021-2030) ($MN)
  • Table 4 Global Microneedle Drug Delivery Systems Market Outlook, By Hollow Microneedle Technology (2021-2030) ($MN)
  • Table 5 Global Microneedle Drug Delivery Systems Market Outlook, By Solid Microneedle Technology (2021-2030) ($MN)
  • Table 6 Global Microneedle Drug Delivery Systems Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 7 Global Microneedle Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 8 Global Microneedle Drug Delivery Systems Market Outlook, By Dissolving Microneedle Technology (2021-2030) ($MN)
  • Table 9 Global Microneedle Drug Delivery Systems Market Outlook, By Porous Microneedles (2021-2030) ($MN)
  • Table 10 Global Microneedle Drug Delivery Systems Market Outlook, By 3D-Printed Microneedles (2021-2030) ($MN)
  • Table 11 Global Microneedle Drug Delivery Systems Market Outlook, By Hydrogel Microneedles (2021-2030) ($MN)
  • Table 12 Global Microneedle Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 13 Global Microneedle Drug Delivery Systems Market Outlook, By Material (2021-2030) ($MN)
  • Table 14 Global Microneedle Drug Delivery Systems Market Outlook, By Biodegradable Microneedle Materials (2021-2030) ($MN)
  • Table 15 Global Microneedle Drug Delivery Systems Market Outlook, By Ceramics (2021-2030) ($MN)
  • Table 16 Global Microneedle Drug Delivery Systems Market Outlook, By Metal (2021-2030) ($MN)
  • Table 17 Global Microneedle Drug Delivery Systems Market Outlook, By Metal Alloys (2021-2030) ($MN)
  • Table 18 Global Microneedle Drug Delivery Systems Market Outlook, By Polymer (2021-2030) ($MN)
  • Table 19 Global Microneedle Drug Delivery Systems Market Outlook, By Silicon (2021-2030) ($MN)
  • Table 20 Global Microneedle Drug Delivery Systems Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 21 Global Microneedle Drug Delivery Systems Market Outlook, By Application (2021-2030) ($MN)
  • Table 22 Global Microneedle Drug Delivery Systems Market Outlook, By Cancer Therapy (2021-2030) ($MN)
  • Table 23 Global Microneedle Drug Delivery Systems Market Outlook, By Dermatology (2021-2030) ($MN)
  • Table 24 Global Microneedle Drug Delivery Systems Market Outlook, By Hormone Delivery (2021-2030) ($MN)
  • Table 25 Global Microneedle Drug Delivery Systems Market Outlook, By Insulin Delivery (2021-2030) ($MN)
  • Table 26 Global Microneedle Drug Delivery Systems Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 27 Global Microneedle Drug Delivery Systems Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 28 Global Microneedle Drug Delivery Systems Market Outlook, By Pediatric Medicine (2021-2030) ($MN)
  • Table 29 Global Microneedle Drug Delivery Systems Market Outlook, By Transdermal Drug Delivery (2021-2030) ($MN)
  • Table 30 Global Microneedle Drug Delivery Systems Market Outlook, By Vaccine Delivery (2021-2030) ($MN)
  • Table 31 Global Microneedle Drug Delivery Systems Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 32 Global Microneedle Drug Delivery Systems Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Global Microneedle Drug Delivery Systems Market Outlook, By Pharmacies (2021-2030) ($MN)
  • Table 34 Global Microneedle Drug Delivery Systems Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 35 Global Microneedle Drug Delivery Systems Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 36 Global Microneedle Drug Delivery Systems Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.